Author:
Garjani Afagh,Patel Sameer,Bharkhada Dhiren,Rashid Waqar,Coles Alasdair,Law Graham R,Evangelou Nikos
Subject
Neurology (clinical),Neurology,General Medicine
Reference14 articles.
1. Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies;Achiron;Ther. Adv. Neurol. Disord.,2021
2. Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy;Apostolidis;Nat. Med.,2021
3. Humoral and T-Cell Response to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis Treated With Ocrelizumab;Brill;JAMA Neurol.,2021
4. Multiple sclerosis, disease-modifying therapies and covid-19: a systematic review on immune response and vaccination recommendations;Cabreira;Vaccines (Basel),2021
5. Beta interferons as immunotherapy in multiple sclerosis: a new outlook on a classic drug during the COVID-19 pandemic;Dumitrescu;QJM,2021
Cited by
42 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献